In addition, it was not possible to evaluate the total daily dose of insulin used, preconception HbA1c values and other parameters of glycemic control, such as time in range and the presence of hypoglycemia during pregnancy, since a small portion of patients had access to CGM in this sample. This evidence concerns the gene INS and Hypoglycemia.